Thorough and responsive counsel for health care providers

Jaya White represents a wide range of health care clients—primarily in the long-term care industry—in regulatory and transactional matters. She also has ample experience advising pharmacy, physician, wholesale distribution and infusion providers in a broad array of issues. Jaya's clients include:

• Buyers, sellers and investors in the sale or purchase of long-term care facilities
• Skilled nursing facilities
• Assisted living facilities
• Independent living facilities
• Continuing care retirement communities
• Home health, home infusion and hospice providers
• Behavioral health providers
• Pharmacies
• Clinical laboratories

Jaya understands the rapidly evolving world of the health care industry and stays current on the regulatory landscape so she can immediately guide her clients with their changing needs. Clients appreciate her thorough analysis and responsive nature when issues arise.

Jaya is the Chicago office chair of the Health & Life Sciences Group. Additionally, she is the national co-chair of the Long-term Care Practice, the Clinical Laboratories practice and the Behavioral Health Providers practice.

Bar Admissions

• Illinois

Education

• The Ohio State University (B.S., magna cum laude, 2002)
  • Major: Business Administration
  • University Honors Program

• The Ohio State University Moritz College of Law (J.D., 2006)
  • Ohio State Law Journal, associate editor (2005–2006); staff member (2004–2005)

• "340B and the OIG Work Plan"
• "340B Discount Drug Program: Updates and Changes Affecting Contract Pharmacies"
• "A Knowledge Infusion: A Legal Overview of Infusion Pharmacy Services"
• "Assisted Living Facilities in the State of Indiana: The Survey Process and Reporting Requirements"
• "Cyber Health Crisis: How to Manage the Risk"
• "Don't Smile: Cameras in Assisted Living are Trouble"
• "Don't Smile: Cameras in Long Term Care are Trouble"
• "Green Illinois: One Midwestern State Charts its Own Course on Recreational and Medical Cannabis"
• "New Illinois Nursing Home Law Double-edged Sword Regarding Privacy"
• "Nursing facility takes a creative path to skirt Medicare termination"
• "Permissive Exclusion: OIG Proposes Rule Creating More Problems, Not Solutions for Long Term Care Providers"
• "Snapchat, Facebook, and Instagram, Oh My! Social Media, Resident Abuse, HIPAA, and Long Term Care"
• "The Impact of the Dobbs Decision on Pharmacy"
• "The Keys Are Under the Mat: Closing a Medicare Certified Skilled Nursing Facility"
• "The Keys are Under the Mat: Closing a Medicare Certified SNF"
• "What I Wish I Knew Then"
• Attention Nursing Facilities: Immediate Imposition of Civil Money Penalties
• CMS Suspends Surveys for Long-Term Care Providers, Issues COVID-19 Protocols
• COVID-19: Illinois Executive Order Grants Civil Immunity to Assisted Living Providers
• DOJ, State AGs Innovate to Fight Covid-19 Fraud
• FDA REMS Protocol Modification Provides a Pathway for Pharmacies to Dispense Mifepristone
• Illinois Proposes Licensure for Pharmacists-in-Charge of Nonresident Pharmacies
• Indiana Family and Social Services Administration Issues its Own COVID-19 Related Guidance Impacting Long-Term Care Facilities
• Indiana State Department of Health Continues to Issue Guidance Related to the Effects of COVID-19 on Long-Term Care Facilities
• Jaya White and Katie Lavigne Author Pharmacy Times Article About Questions Surrounding Mifepristone Distribution by Mail Order Pharmacies
• Jaya White and Katie Lavigne Outline Mifepristone Considerations for Pharmacies in Article for Healthcare Business Today
• Long-Term Care Providers: CMS Blanket Waivers and Guidance from the Indiana State Department of Health on Hospital Discharges
• Long-Term Care Providers: CMS Issues Guidance for Infection Control and Prevention Concerning COVID-19 in Home Health Agencies
• Long-Term Care Providers: Restrictions on Visitors in Light of COVID-19
• Long-Term Care: More Changes to the Survey Process
• Navigating Abortion Restrictions Post Dobbs: Considerations for Pharmacy Providers
• New CMS Regulation Prohibits Nursing Facilities from Using Pre-Admission Binding Arbitration Agreements
• Pharmacy Promotional Activities, Their Impact and Their Future: Coupons, Gift Cards, Reward Programs and Inducements”
• Quarles Partners Assess Risks to COVID-19 Testing Labs of Increased FCA Scrutiny in Article for Bloomberg Law
• Restrictions on Communal Dining for Long-Term Care Providers During COVID-19
• Snapchat, Facebook, and Instagram….Has Your Facility Addressed These Media in Your Resident Abuse Prevention Policies?  Now is the Time…the Surveyors are Coming!
• “2014 OIG Work Plan”
• “340B Toolkit”
• “Developments in the Law: Noncompete Agreements”
• “Heightened Regulatory Scrutiny Facing Innovative POD Arrangements"
• “HIPAA in a HITECH World”
• “Hiring Wisely: Enforceability of Employment Agreements, Covenants Not to Compete, and Non-Solicitation/Confidentiality Clauses”
• “Hot Topics in Medicare Reimbursement”
• “Legal Update”
• “Medicare Legislative Changes Since the Affordable Care Act”
• “What’s Next in Health Care Reform for 2014”

Seminar

• 2023 Pharmacy Law Symposium
• IAHA 2019 Annual Health Law Symposium
• Infusion Pharmacy Services: Regulatory Considerations Impacting the Business Model
• Navigating the Post-PHE Landscape: Law and Policy Changes for the Healthcare Industry
• Pathways to Success: Corporate Counsel Partner with Chicago Law Firms on Law Diversity